A case of Fournier's gangrene following a large-volume hydrocelectomy in a diabetic patient managed with SGLT-2 inhibitor therapy
Dapagliflozin (Farxiga), is an SGLT-2 inhibitor commonly indicated for the treatment of diabetes mellitus type 2 (DM 2), heart failure, and chronic kidney disease. One rare side effect associated with SGLT-2 inhibitors is bacterial infection of the genitalia. There are several case reports highlight...
Main Authors: | Ethan Vargo, Giovanna Leone, Oren Barat, Aaron Yunker, Neel Parekh |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-11-01
|
Series: | Urology Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214442021002746 |
Similar Items
-
Bitter sweet: Fournier’s Gangrene and SGLT2 inhibitors
by: Coralea Kappel
Published: (2019-12-01) -
Gangrena de Fournier Fournier's gangrene
by: Emilio Simón Barroso de la Cruz, et al.
Published: (2005-12-01) -
Fournier′s gangrene of the penis
by: Tauro Leo, et al.
Published: (2005-01-01) -
Prognostic factors in Fournier gangrene
by: Jaime Ruiz-Tovar, et al.
Published: (2012-01-01) -
Pattern and outcome of management of Fournier's gangrene in a resource-constraint setting
by: Ngwobia Peter Agwu, et al.
Published: (2020-01-01)